Impact of Social Determinants of Health on Outcomes Following Resection for Hepatocellular Carcinoma

被引:3
|
作者
Moten, Ambria S. [1 ]
Dickson, Paxton, V [1 ]
Deneve, Jeremiah L. [1 ]
Shibata, David [1 ,2 ]
Stanfill, Ansley G. [3 ]
Glazer, Evan S. [1 ,2 ]
机构
[1] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Memphis, TN 38163 USA
[2] Univ Tennessee, Ctr Hlth Sci, Coll Med, Ctr Canc Res, Memphis, TN 38163 USA
[3] Univ Tennessee, Ctr Hlth Sci, Coll Nursing, Dept Acute & Tertiary Care, Memphis, TN 38163 USA
关键词
LIVER-TRANSPLANTATION; HEPATIC RESECTION; SURVIVAL; READMISSION; RACE; DISPARITIES;
D O I
10.1245/s10434-022-12735-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background We sought to determine the impact of social determinants of health (SDoH) on outcomes of patients undergoing resection for hepatocellular carcinoma (HCC). Patients and Methods Patients with HCC in the National Cancer Database who underwent resection from 2009 to 2018 were identified. SDoH associated with length of stay (LOS), 30-day readmission, and 30-day mortality were analyzed using regression analyses adjusted for confounding variables. Results Among 9235 patients, the median age (range) was 65.0 (18-90) years, 72.1% were male, and 57.9% were White. A total of 3% were uninsured, 11.1% had Medicaid, 21% resided in regions with a median household income within the lowest quartile of the US population, and 27.0% resided in regions within the lowest quartile of education level. The odds for having longer LOS were lower among patients with the highest regional education level compared with those with the lowest level [odds ratio (OR) 0.86, 95% confidence interval (CI) 0.77-0.97]. The risk of readmission was lower among patients with Medicare (OR 0.52; 95% CI 0.33-0.81), Medicaid (OR 0.52; 95% CI 0.31-0.87), or private insurance (OR 0.56; 95% CI 0.35-0.88) compared with uninsured patients. Thirty-day overall mortality was less likely among patients with Medicare (OR 0.45; 95% CI 0.27-0.75), Medicaid (OR 0.53; 95% CI 0.30-0.93), or private insurance (OR 0.40; 95% CI 0.24-0.66), and among patients with high regional income (OR 0.58; 95% CI 0.44-0.77). Conclusions Adjusted regression analyses identified SDoH that were associated with HCC outcomes. Increased awareness of how SDoH relate to outcomes may inform strategies that attempt to account for these associations and improve patient outcomes.
引用
收藏
页码:738 / 747
页数:10
相关论文
共 50 条
  • [1] Impact of Social Determinants of Health on Outcomes Following Resection for Hepatocellular Carcinoma
    Ambria S. Moten
    Paxton V. Dickson
    Jeremiah L. Deneve
    David Shibata
    Ansley G. Stanfill
    Evan S. Glazer
    Annals of Surgical Oncology, 2023, 30 : 738 - 747
  • [2] The Impact of Social Determinants of Health on Outcomes Following Surgery for Hepatocellular Carcinoma
    Moten, Ambria
    Dickson, Paxton
    Deneve, Jeremiah
    Stanfill, Ansley
    Shibata, David
    Glazer, Evan
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 455 - 456
  • [3] ASO Visual Abstract: The Impact of Social Determinants of Health on Outcomes After Resection for Hepatocellular Carcinoma
    Ambria S. Moten
    Paxton V. Dickson
    Jeremiah L. Deneve
    David Shibata
    Ansley G. Stanfill
    Evan S. Glazer
    Annals of Surgical Oncology, 2023, 30 : 748 - 749
  • [4] ASO Visual Abstract: The Impact of Social Determinants of Health on Outcomes After Resection for Hepatocellular Carcinoma
    Moten, Ambria S.
    Dickson, Paxton V.
    Deneve, Jeremiah L.
    Shibata, David
    Stanfill, Ansley G.
    Glazer, Evan S.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (02) : 748 - 749
  • [5] Impact of Social Determinants of Health (SDH) on Outcomes in Patients with Hepatocellular Carcinoma (HCC)
    Ponce, S. E. Beltran
    Gokun, Y.
    Pitter, K. L.
    Thomas, C. R., Jr.
    Miller, E. D.
    Conteh, L.
    Douglass, F.
    Pardo, D. A. Diaz
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E172 - E173
  • [6] Impact of social determinants of health on hepatocellular carcinoma surveillance, treatment, and health care costs
    Singal, Amit G.
    Kilgore, Karl M.
    Shvets, Elizabet
    Parikh, Neehar D.
    Mehta, Neil
    Ozbay, A. Burak
    Teigland, Christie
    Hafez, Omar
    Schroeder, Amy
    Yang, Audrey
    Schinkel, Jill
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (11)
  • [7] Outcomes Following Resection of Hepatocellular Carcinoma in the Absence of Cirrhosis
    Lewis, Richard H.
    Glazer, Evan S.
    Bittenbinder, David M.
    O'Brien, Thomas
    Deneve, Jeremiah L.
    Shibata, David
    Behrman, Stephen W.
    Vanatta, Jason M.
    Satapathy, Sanjaya K.
    Dickson, Paxton V.
    JOURNAL OF GASTROINTESTINAL CANCER, 2019, 50 (04) : 808 - 815
  • [8] Outcomes Following Resection of Hepatocellular Carcinoma in the Absence of Cirrhosis
    Richard H. Lewis
    Evan S. Glazer
    David M. Bittenbinder
    Thomas O’Brien
    Jeremiah L. Deneve
    David Shibata
    Stephen W. Behrman
    Jason M. Vanatta
    Sanjaya K. Satapathy
    Paxton V. Dickson
    Journal of Gastrointestinal Cancer, 2019, 50 : 808 - 815
  • [9] The Impact of Social Determinants of Health on Survival and Disease Severity in Patients With Hepatocellular Carcinoma
    Farah, Bassem
    Manivannan, Ahila
    Harris, Kevin
    Salgia, Reena
    Michelle, Jesse
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S926 - S926
  • [10] DETERMINANTS OF PATIENTS OUTCOMES FOLLOWING LOCOREGIONAL ABLATION OF HEPATOCELLULAR CARCINOMA
    Ali, Mohamed A.
    Roberts, Lewis R.
    Harmsen, William S.
    Therneau, Terry
    GASTROENTEROLOGY, 2018, 154 (06) : S1239 - S1239